Clinical Trial

Albuterol and Immune Cell Composition

Study Description

Albuterol and Immune Cell Composition

The aim of this pilot study is to determine the effects of albuterol on the composition of immune cells in the bloodstream for possible future use in patients with neuroblastoma.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Administration of albuterol

Participants will inhale nebulized albuterol at a concentration of 2.5mg diluted in 3mL of normal saline for 20 minutes.

Additional Information

Official Study Title

Albuterol and Immune Cell Composition

Clinical Trial ID

NCT03889379

ParticipAid ID

dBBpWd